5/23/24 - $mlab - best to avoid tough setup in tough tape ignore5/23/24 - vrockstar - NASDAQ:MLAB - looks like a trap w/o proper DD or insight on trends. 5% yield fine for growth, but 100%+ of it is stock comp on a sinking currency (the stock). if you take out R&D, the GP growth is simply a function of uptick in sales growth, no leverage here and increasing R&
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.5 EUR
−1.82 M EUR
222.75 M EUR
5.35 M
About Mesa Laboratories, Inc.
Sector
Industry
CEO
Gary M. Owens
Website
Headquarters
Lakewood
Founded
1982
FIGI
BBG000GT67G9
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MLAB4870321
Mesa Laboratories, Inc. 1.375% 15-AUG-2025Yield to maturity
7.50%
Maturity date
Aug 15, 2025
See all MLI bonds
Frequently Asked Questions
The current price of MLI is 66.0 EUR — it has decreased by −4.11% in the past 24 hours. Watch MESA LABS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MESA LABS INC. stocks are traded under the ticker MLI.
MLI stock has fallen by −10.83% compared to the previous week, the month change is a −17.16% fall, over the last year MESA LABS INC. has showed a −29.41% decrease.
We've gathered analysts' opinions on MESA LABS INC. future price: according to them, MLI price has a max estimate of 118.71 EUR and a min estimate of 84.79 EUR. Watch MLI chart and read a more detailed MESA LABS INC. stock forecast: see what analysts think of MESA LABS INC. and suggest that you do with its stocks.
MLI stock is 6.06% volatile and has beta coefficient of 1.21. Track MESA LABS INC. stock price on the chart and check out the list of the most volatile stocks — is MESA LABS INC. there?
Today MESA LABS INC. has the market capitalization of 367.87 M, it has decreased by −8.00% over the last week.
Yes, you can track MESA LABS INC. financials in yearly and quarterly reports right on TradingView.
MESA LABS INC. is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
MLI earnings for the last quarter are 2.08 EUR per share, whereas the estimation was 2.12 EUR resulting in a −1.89% surprise. The estimated earnings for the next quarter are 1.93 EUR per share. See more details about MESA LABS INC. earnings.
MESA LABS INC. revenue for the last quarter amounts to 57.43 M EUR, despite the estimated figure of 57.22 M EUR. In the next quarter, revenue is expected to reach 51.42 M EUR.
MLI net income for the last quarter is −6.58 M EUR, while the quarter before that showed −1.62 M EUR of net income which accounts for −306.17% change. Track more MESA LABS INC. financial stats to get the full picture.
Yes, MLI dividends are paid quarterly. The last dividend per share was 0.14 EUR. As of today, Dividend Yield (TTM)% is 0.83%. Tracking MESA LABS INC. dividends might help you take more informed decisions.
As of Jul 16, 2025, the company has 730 employees. See our rating of the largest employees — is MESA LABS INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MESA LABS INC. EBITDA is 37.77 M EUR, and current EBITDA margin is 16.96%. See more stats in MESA LABS INC. financial statements.
Like other stocks, MLI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MESA LABS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MESA LABS INC. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MESA LABS INC. stock shows the strong sell signal. See more of MESA LABS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.